Publication & Citation Trends
Publications
0 total
Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models
Cited by 1
Semantic Scholar
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial OA
Cited by 33
Semantic Scholar
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design OA
Cited by 172
Semantic Scholar
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Cited by 473
Semantic Scholar
Genomic profiling of three pathways through molecular profiling-based assignment of cancer therapy (NCI- MPACT) OA
Cited by 1
Semantic Scholar
The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality. OA
Cited by 34
Semantic Scholar
Applying High-Throughput Molecular Techniques to FFPE Clinical Tissues — DNA and mRNA
Cited by 0
Semantic Scholar
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer OA
Cited by 54
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(15)
Ovarian cancer diagnosis and treatment
(13)
Lymphoma Diagnosis and Treatment
(12)
BRCA gene mutations in cancer
(10)
PARP inhibition in cancer therapy
(10)
Affiliations
Leidos (United States)
Novartis (Switzerland)
Boston Medical Center
National Yang Ming Chiao Tung University
Emory University